| Hemolytic uremic syndrome in pregnancy and postpartum A Bruel, D Kavanagh, M Noris, Y Delmas, EKS Wong, E Bresin, F Provôt, ... Clinical Journal of the American Society of Nephrology 12 (8), 1237-1247, 2017 | 220 | 2017 |
| The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment E Rondeau, M Scully, G Ariceta, T Barbour, S Cataland, N Heyne, ... Kidney International 97 (6), 1287-1296, 2020 | 162 | 2020 |
| Diseases of complement dysregulation—an overview EKS Wong, D Kavanagh Seminars in immunopathology 40 (1), 49-64, 2018 | 126 | 2018 |
| Whole-exome sequencing identifies rare, functional CFH variants in families with macular degeneration Y Yu, MP Triebwasser, EKS Wong, EC Schramm, B Thomas, R Reynolds, ... Human molecular genetics 23 (19), 5283-5293, 2014 | 118 | 2014 |
| Complement therapy in atypical haemolytic uraemic syndrome (aHUS) EKS Wong, THJ Goodship, D Kavanagh Molecular immunology 56 (3), 199-212, 2013 | 106 | 2013 |
| Anticomplement C5 therapy with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome EKS Wong, D Kavanagh Translational Research 165 (2), 306-320, 2015 | 93 | 2015 |
| An extended mini-complement factor H molecule ameliorates experimental C3 glomerulopathy EM Nichols, TD Barbour, IY Pappworth, EKS Wong, JM Palmer, ... Kidney international 88 (6), 1314-1322, 2015 | 77 | 2015 |
| Factor H autoantibody is associated with atypical hemolytic uremic syndrome in children in the United Kingdom and Ireland V Brocklebank, S Johnson, TP Sheerin, SD Marks, RD Gilbert, K Tyerman, ... Kidney international 92 (5), 1261-1271, 2017 | 71 | 2017 |
| Telomerecat: A ploidy-agnostic method for estimating telomere length from whole genome sequencing data JHR Farmery, ML Smith, AG Lynch Scientific reports 8 (1), 1300, 2018 | 69 | 2018 |
| The role of ADAMTS‐13 activity and complement mutational analysis in differentiating acute thrombotic microangiopathies EH Phillips, JP Westwood, V Brocklebank, EKS Wong, JO Tellez, ... Journal of Thrombosis and Haemostasis 14 (1), 175-185, 2016 | 57 | 2016 |
| Characterization of a factor H mutation that perturbs the alternative pathway of complement in a family with membranoproliferative GN EKS Wong, HE Anderson, AP Herbert, RC Challis, P Brown, GS Reis, ... Journal of the American Society of Nephrology 25 (11), 2425-2433, 2014 | 54 | 2014 |
| Thrombotic microangiopathy in inverted formin 2–mediated renal disease RC Challis, T Ring, Y Xu, EKS Wong, O Flossmann, ISD Roberts, ... Journal of the American Society of Nephrology 28 (4), 1084-1091, 2017 | 53 | 2017 |
| A De Novo Deletion in the Regulators of Complement Activation Cluster Producing a Hybrid Complement Factor H/Complement Factor H–Related 3 Gene in Atypical Hemolytic Uremic … RC Challis, GSR Araujo, EKS Wong, HE Anderson, A Awan, AM Dorman, ... Journal of the American Society of Nephrology 27 (6), 1617-1624, 2016 | 52 | 2016 |
| Long-term efficacy and safety of the long-acting complement C5 inhibitor ravulizumab for the treatment of atypical hemolytic uremic syndrome in adults T Barbour, M Scully, G Ariceta, S Cataland, K Garlo, N Heyne, Y Luque, ... Kidney international reports 6 (6), 1603-1613, 2021 | 42 | 2021 |
| Long-term outcomes and response to treatment in diacylglycerol kinase epsilon nephropathy V Brocklebank, G Kumar, AJ Howie, J Chandar, DV Milford, J Craze, ... Kidney international 97 (6), 1260-1274, 2020 | 40 | 2020 |
| Large-scale whole-genome sequencing reveals the genetic architecture of primary membranoproliferative GN and C3 glomerulopathy AP Levine, MMY Chan, O Sadeghi-Alavijeh, EKS Wong, HT Cook, ... Journal of the American Society of Nephrology 31 (2), 365-373, 2020 | 39 | 2020 |
| Disease-linked mutations in factor H reveal pivotal role of cofactor activity in Self-surface–selective regulation of complement activation H Kerr, E Wong, E Makou, Y Yang, K Marchbank, D Kavanagh, ... Journal of Biological Chemistry 292 (32), 13345-13360, 2017 | 32 | 2017 |
| Efficacy and safety of iptacopan in patients with C3 glomerulopathy E Wong, C Nester, T Cavero, A Karras, M Le Quintrec, L Lightstone, ... Kidney international reports 8 (12), 2754-2764, 2023 | 20 | 2023 |
| C3 glomerulopathy and related disorders in children: etiology-phenotype correlation and outcomes EKS Wong, KJ Marchbank, H Lomax-Browne, IY Pappworth, H Denton, ... Clinical Journal of the American Society of Nephrology 16 (11), 1639-1651, 2021 | 19 | 2021 |
| Functional characterization of rare genetic variants in the N-terminus of complement factor H in aHUS, C3G, and AMD EKS Wong, TM Hallam, V Brocklebank, PR Walsh, K Smith-Jackson, ... Frontiers in immunology 11, 602284, 2021 | 17 | 2021 |
Prof David KavanaghProfessor of Complement Therapeutics, National Renal Complement Therapeutics Centre在 ncl.ac.uk 的电子邮件经过验证
